What is Stiolto Respimat used for?
Stiolto Respimat is a prescription inhaler used to treat chronic obstructive pulmonary disease (COPD). It contains two long-acting bronchodilators—tiotropium and olodaterol—that help keep the airways open and make breathing easier over time.
What’s in Stiolto Respimat and how does it work?
Stiolto Respimat combines:
- Tiotropium (a long-acting muscarinic antagonist) to relax airway muscles and reduce tightening of the airways.
- Olodaterol (a long-acting beta2-agonist) to help keep the airways open by relaxing smooth muscle.
Together, the two medicines provide longer-lasting symptom control for COPD.
How do you use Stiolto Respimat?
Stiolto Respimat is used as an inhaler from a Respimat device. Typical COPD maintenance dosing is taken on a fixed schedule, not as a rescue inhaler for sudden breathing problems. If you’re switching from another inhaler, your clinician/pharmacist can walk you through the device steps and timing.
Is Stiolto Respimat a rescue inhaler?
No. Stiolto Respimat is a long-acting maintenance inhaler. It is not intended to treat sudden shortness of breath or acute attacks. Patients are usually prescribed a separate short-acting “rescue” inhaler for emergencies.
What side effects do people report with Stiolto Respimat?
Common side effects can include breathing-related irritation such as throat irritation and cough, plus potential medication-related effects (the exact list depends on the product label and patient risk factors). Patients should seek medical advice promptly for serious symptoms such as chest pain, fainting, or significant worsening breathing.
Who should avoid or use extra caution with Stiolto Respimat?
Extra caution is often needed for people with certain heart rhythm problems, uncontrolled cardiovascular disease, or specific medical conditions where long-acting bronchodilators may pose higher risk. Because Stiolto contains two active medicines, your clinician will weigh your history and current medications before prescribing.
How does Stiolto Respimat compare with other COPD inhalers?
Stiolto Respimat is a “dual long-acting” COPD therapy (LAMA/LABA). Other options include:
- Single long-acting inhalers (either LAMA or LABA)
- “Triple therapy” combinations (LAMA/LABA plus inhaled corticosteroid)
- Different LAMA/LABA combinations from other brands
Which one fits best depends on symptom control, exacerbation history, and tolerability.
Is Stiolto Respimat the same as Spiriva or other tiotropium products?
No. While Stiolto includes tiotropium, it also includes olodaterol. Spiriva products use tiotropium alone, so the dosing, effects, and device may differ.
Patent and competition angle (who makes similar drugs?)
For patent and exclusivity tracking by product and approval stage, DrugPatentWatch.com is a useful reference point: https://www.drugpatentwatch.com/ (search “Stiolto Respimat” there to see related filings and timelines).
---
If you tell me what you need most—how it’s taken, side effects, COPD severity fit, or how it compares to your current inhaler—I can tailor the answer.
Sources:
1. https://www.drugpatentwatch.com/